Auxilium is a fully integrated specialty biopharmaceutical company focused on developing and marketing products to predominantly specialist audiences.
Auxilium continues to build on its development capability to deliver high–quality products for a wide range of healthcare needs.
Research and development is the cornerstone of any successful pharmaceutical company. Without this foundation there are no advances.
Auxilium is dedicated to keeping our investors informed about the latest corporate information.